<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d220" origId="Cefoxitin"><sentence id="DrugDDI.d220.s0" origId="s0" text="Increased nephrotoxicity has been reported following concomitant administration of cephalosporins and aminoglycoside antibiotics."><entity charOffset="83-97" id="DrugDDI.d220.s0.e0" origId="s0.p6" text="cephalosporins" type="drug"/><entity charOffset="102-128" id="DrugDDI.d220.s0.e1" origId="s0.p8" text="aminoglycoside antibiotics" type="drug"/><pair e1="DrugDDI.d220.s0.e0" e2="DrugDDI.d220.s0.e1" id="DrugDDI.d220.s0.p0" interaction="true"/></sentence><sentence id="DrugDDI.d220.s1" origId="s1" text="Drug/Laboratory Test Interactions As with cephalothin, high concentrations of cefoxitin ( 100 micrograms/mL) may interfere with measurement of serum and urine creatinine levels by the Jaff? reaction, and produce false increases of modest degree in the levels of creatinine reported."><entity charOffset="0-4" id="DrugDDI.d220.s1.e0" origId="s1.p9" text="Drug" type="drug"/><entity charOffset="42-53" id="DrugDDI.d220.s1.e1" origId="s1.p12" text="cephalothin" type="drug"/><entity charOffset="78-87" id="DrugDDI.d220.s1.e2" origId="s1.p14" text="cefoxitin" type="drug"/><entity charOffset="262-272" id="DrugDDI.d220.s1.e3" origId="s1.p30" text="creatinine" type="drug"/><pair e1="DrugDDI.d220.s1.e0" e2="DrugDDI.d220.s1.e1" id="DrugDDI.d220.s1.p0" interaction="false"/><pair e1="DrugDDI.d220.s1.e0" e2="DrugDDI.d220.s1.e2" id="DrugDDI.d220.s1.p1" interaction="false"/><pair e1="DrugDDI.d220.s1.e0" e2="DrugDDI.d220.s1.e3" id="DrugDDI.d220.s1.p2" interaction="false"/><pair e1="DrugDDI.d220.s1.e1" e2="DrugDDI.d220.s1.e2" id="DrugDDI.d220.s1.p3" interaction="false"/><pair e1="DrugDDI.d220.s1.e1" e2="DrugDDI.d220.s1.e3" id="DrugDDI.d220.s1.p4" interaction="false"/><pair e1="DrugDDI.d220.s1.e2" e2="DrugDDI.d220.s1.e3" id="DrugDDI.d220.s1.p5" interaction="false"/></sentence><sentence id="DrugDDI.d220.s2" origId="s2" text="Serum samples from patients treated with cefoxitin should not be analyzed for creatinine if withdrawn within 2 hours of drug administration."><entity charOffset="41-50" id="DrugDDI.d220.s2.e0" origId="s2.p35" text="cefoxitin" type="drug"/><entity charOffset="78-88" id="DrugDDI.d220.s2.e1" origId="s2.p40" text="creatinine" type="drug"/><pair e1="DrugDDI.d220.s2.e0" e2="DrugDDI.d220.s2.e1" id="DrugDDI.d220.s2.p0" interaction="false"/><negationtags>Serum samples from patients treated with cefoxitin should &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; be analyzed for creatinine if withdrawn within 2 hours of drug administration&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d220.s3" origId="s3" text="High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported."><entity charOffset="23-32" id="DrugDDI.d220.s3.e0" origId="s3.p46" text="cefoxitin" type="drug"/><entity charOffset="99-114" id="DrugDDI.d220.s3.e1" origId="s3.p51" text="corticosteroids" type="drug"/><pair e1="DrugDDI.d220.s3.e0" e2="DrugDDI.d220.s3.e1" id="DrugDDI.d220.s3.p0" interaction="true"/></sentence><sentence id="DrugDDI.d220.s4" origId="s4" text="A false-positive reaction for glucose in the urine may occur."><entity charOffset="30-37" id="DrugDDI.d220.s4.e0" origId="s4.p60" text="glucose" type="drug"/></sentence><sentence id="DrugDDI.d220.s5" origId="s5" text="This has been observed with CLINITEST? reagent tablets"/><sentence id="DrugDDI.d220.s6" origId="s6" text="."/><sentence id="DrugDDI.d220.s7" origId="s7" text="? Registered trademark of Ames Company, Division of Miles Laboratories, Inc."><entity charOffset="26-29" id="DrugDDI.d220.s7.e0" origId="s7.p70" text="Ame" type="drug"/></sentence></document>